D.L. Carlson Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

D.L. Carlson Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,245	Closed	-$281K	–	135
2016 Q1	$281K	Sell	5,245 -200	-4%	-$11.7K	0.1%	112
2015 Q4	$357K	Sell	5,445 -380	-7%	-$23.5K	0.13%	107
2015 Q3	$329K	Sell	5,825 -1,715	-23%	-$111K	0.13%	105
2015 Q2	$446K	Sell	7,540 -3,310	-31%	-$204K	0.16%	112
2015 Q1	$676K	Sell	10,850 -21,400	-66%	-$1.24M	0.24%	104
2014 Q4	$1.85M	Buy	32,250 +6,770	+27%	+$377K	0.67%	63
2014 Q3	$1.37M	Buy	25,480 +2,555	+11%	+$135K	0.51%	76
2014 Q2	$1.2M	Sell	22,925 -325	-1%	-$16.6K	0.44%	83
2014 Q1	$1.23M	Buy	+23,250	New	+$1.07M	0.46%	81

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.L. Carlson Investment Group's TEVA Position: Q2 2016 in Review

D.L. Carlson Investment Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 5,245 shares — an estimated $281K sold.

D.L. Carlson Investment Group first reported a position in TEVA in Q1 2014 and held it in 9 quarters. The position peaked at $1.85M in Q4 2014. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

D.L. Carlson Investment Group reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
D.L. Carlson Investment Group sold 5,245 Teva Pharmaceuticals shares in Q2 2016, an estimated $281K.
D.L. Carlson Investment Group first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 9 quarters.
D.L. Carlson Investment Group's Teva Pharmaceuticals position peaked at $1.85M in Q4 2014.
812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2016, filed 10 Aug 2016.